This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Cryoport, Inc., the leading provider of advanced cryogenic logisticssolutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, announced that the Company has expanded its relationship with Capricor Therapeutics ("Capricor") to provide a comprehensive cryogenic logistics solution to support both their ALLSTAR and DYNAMIC clinical trials.
Capricor, based in Los Angeles, California, is a clinical-stage biotechnology company focused on the development and commercialization of innovative therapies to treat cardiovascular diseases. Capricor's lead product candidate, CAP-1002, is an allogeneic, off-the-shelf cell therapy derived from donor heart tissue and infused into a patient's coronary artery. The Company is responsible for the cryogenic logistics that will serve these multi-center trials.
Linda Marbán, Chief Executive Officer of Capricor, commented, "Cryoport has provided valuable cryogenic logistics support for our lead clinical program. We are grateful for their expertise and their support in a role that is contributing greatly to our progress."
Jerrell Shelton, Chief Executive Officer of Cryoport, stated, "It is our understanding that Capricor's approach to the cardiac space is unique and has potentially great promise in treating cardiovascular disease. We are excited to be able to support the continued progression of Capricor's clinical trial work. Our best-in-class cryogenic logistics solutions are key components to providing the worldwide access that is required by our clients to successfully conduct their clinical trials. We take very seriously the fact that the Capricor patients enrolled in these trials are dependent on our services that allow them to participate in a program that could potentially lead to the treatment of their disease."
>> For more information, click here
